Features

Experimental Treatment Pivots in Record Time At the beginning of 2020, everyone in research and medicine who could pivot to focus on COVID-19 did. Scientists and ...

Ever since Antonie van Leeuwenhoek spotted "animalcules" with his first crude microscope lens, microscopy has been a mainstay of the science of small. In the ...

Humanity has taken on infectious agents, such as the virus that causes smallpox, and won. But cheer quietly. Smallpox eradication took 200 years, and it's ...

A year after the first case of COVID-19 was reported in the U.S., more than 26 million Americans are confirmed to have had this disease, ...

Current experimental treatments for COVID-19 focus on two targets: the virus or the immune system.  On the immune system side, the number of experimental treatments ...

Researchers from Massachusetts Institute of Technology and Mayo Clinic announce news of a proof-of-concept patch for surgical and emergency situations where stitches or staples would ...

While the SARS-CoV-2 virus that causes COVID-19 continues to evolve, there are vaccines developed so far that prevent severe COVID-19. However, they approach their goal ...

Five years ago, Jay Schneider, M.D., Ph.D., was running a lab at The University of Texas Southwestern Medical Center in Dallas. The lab focused on ...

On Thursday, Nov. 19, Mayo Clinic began offering an experimental therapy to patients who test positive for COVID-19 and are at high risk for serious ...

Clinical trial data for COVID-19 vaccine candidates were released this week. Currently named BNT162b2 and mRNA-1273, these genetic vaccine use our cell’s ability to read ...